StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)

Close on Nov 12, 2026Market cap $1.35BP/E –Yield –

PROCEPT BioRobotics gross margin

Gross margin is gross profit as a percentage of revenue.

PROCEPT BioRobotics's gross margin for the twelve months ending Sep 30, 2026 was 64.7%. For fiscal 2025 it was 63.7%, against 61.1% the year before. The highest annual figure on record is 63.7% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202563.7%+2.6
FY2024Dec 31, 202461.1%+8.9
FY2023Dec 31, 202352.2%+2.7
FY2022Dec 31, 202249.4%+3.4
FY2021Dec 31, 202146.0%+62.3
FY2020Dec 31, 2020-16.3%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202666.3%+1.5
Q2 FY2026Jun 30, 202666.0%+0.7
Q1 FY2026Mar 31, 202664.9%+1.0
Q4 FY2025Dec 31, 202560.6%−3.4
Q3 FY2025Sep 30, 202564.8%+1.6
Q2 FY2025Jun 30, 202565.4%+6.3
Q1 FY2025Mar 31, 202563.9%+7.6
Q4 FY2024Dec 31, 202464.0%+15.2
Q3 FY2024Sep 30, 202463.2%+9.5
Q2 FY2024Jun 30, 202459.0%+3.3
Q1 FY2024Mar 31, 202456.2%+5.0
Q4 FY2023Dec 31, 202348.8%+3.9
Q3 FY2023Sep 30, 202353.8%+3.5
Q2 FY2023Jun 30, 202355.7%+4.8
Q1 FY2023Mar 31, 202351.2%−3.0
Q4 FY2022Dec 31, 202244.9%+0.4
Q3 FY2022Sep 30, 202250.3%+1.4
Q2 FY2022Jun 30, 202250.8%+8.6
Q1 FY2022Mar 31, 202254.2%+5.1
Q4 FY2021Dec 31, 202144.5%+30.0
Q3 FY2021Sep 30, 202148.9%+50.4
Q2 FY2021Jun 30, 202142.3%–
Q1 FY2021Mar 31, 202149.0%–
Q4 FY2020Dec 31, 202014.6%–
Q3 FY2020Sep 30, 2020-1.5%–

More PROCEPT BioRobotics figures

See a number that looks wrong?